Regeneron Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Tarrytown, NY
REGN chart
What traders are saying about $REGN
Latest postsRegeneron Pharmaceuticals, Inc. news
- Here’s How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years
Benzinga ·
- Has Regeneron Stock Become A Different Bet?
trefis.com ·
- How Inmazeb Deal Extension Will Impact Regeneron Stock (REGN)
Simply Wall Street ·
- Regeneron agrees to $270m extension to supply Ebola medicine in US
pharmaceutical-technology.com ·
- Regeneron Pharmaceuticals, Inc. (REGN) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Regeneron Pharmaceuticals (REGN) Posts Nearly Four Years Of Survival Benefit Data For Libtayo
Yahoo Finance ·
- Regeneron Pharmaceuticals (REGN) Q3 2026 Preview: EPS Est. $16.19, Reports October 30
AlphaStreet ·
- Regeneron Expands Ebola Supply Deal by $270 Million
grafa.com ·
- Regeneron extends US agreement for additional supply of Ebola treatment
Reuters ·
- Regeneron’s Billion-Dollar Catalyst Flying Under Wall Street’s Radar Ahead of Oct. 30 Earnings
247wallst.com ·
- Analysts Estimate Jazz Pharmaceuticals (JAZZ) to Report a Decline in Earnings: What to Look Out for
Yahoo Finance ·
- Regeneron Pharmaceuticals (REGN) Could Be 5% Undervalued Following Fresh Libtayo Phase 3 Data
Simply Wall Street ·
Regeneron Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $14.34B | $14.20B | $13.12B | $12.17B |
| Net income | $4.50B | $4.41B | $3.95B | $4.34B |
| Diluted EPS | $41.48 | $38.34 | $34.77 | $38.22 |
| Total assets (year end) | $40.56B | $37.76B | $33.08B | $29.21B |
| Cash and equivalents (year end) | $3.12B | $2.49B | $2.73B | $3.11B |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Regeneron Pharmaceuticals, Inc.
- Ticker
- REGN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Tarrytown, NY
- Incorporated in
- NY
- Fiscal year end
- December 31
- SEC CIK
- 872589
- Former names
- REGENERON PHARMACEUTICALS INC
Frequently asked questions
What exchange is Regeneron Pharmaceuticals, Inc. listed on?
Regeneron Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol REGN.
What industry is Regeneron Pharmaceuticals, Inc. in?
Regeneron Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Regeneron Pharmaceuticals, Inc. headquartered?
Regeneron Pharmaceuticals, Inc.'s business address on file with the SEC is in Tarrytown, NY.
When does Regeneron Pharmaceuticals, Inc.'s fiscal year end?
Regeneron Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Regeneron Pharmaceuticals, Inc. report?
Regeneron Pharmaceuticals, Inc. reported $14.34B in revenue for calendar year 2025, according to its SEC filings.